The latest immunotherapy news and developments
In a presentation of real-world data, researchers from Fox Chase Cancer Center, USA, have concluded…
Patients with high-risk melanoma who had a course of pembrolizumab after their surgery had a…
“Certain patients with advanced oesophageal cancer, who currently have few treatment options, now stand to…
Immunotherapy after surgery significantly improved disease-free survival (DFS) for patients with the most common type…
The addition of the immunotherapy agent toripalimab to standard first-line chemotherapy significantly delayed disease progression…
In a presentation of real-world data, researchers from Fox Chase Cancer Center, USA, have concluded…
In the longest follow-up results from a clinical trial of combination immunotherapy for metastatic melanoma,…
A novel form of macrophage-based immunotherapy is effective at treating a broad spectrum of cancers,…
A long noncoding RNA whose function was previously unknown turns out to play an important…
“Immunotherapy has transformed the outlook for patients with advanced melanoma. The success seen in this…